DC-CTL cell infusion

Dendritic Cytotoxic Lymphocyte (DC-CTL) cell infusion · Shenzhen Hornetcorn Bio-technology Company, LTD

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DC-CTL cell infusion, covering 2016-05-09 to 2016-05-09. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Efficacy and Safety of Dendritic Cytotoxic Lymphocyte(DC-CTL) Cell Infusion in NSCLC Patients [Phase 2]